June 1, 2023
The companies agree to a worldwide Human Platelet Lysate (HPL) Patent License and Assignment Agreement, including redirection of HPL customers from Macopharma to PL BioScience. AACHEN, Germany -- PL BioScience GmbH, a German life science company specializing in the production and development of Human Platelet Lysate (HPL) for cell expansion, today announced a Patent License [...]
June 1, 2023
Highly multiplexed, patented and patent-pending GT-Plex™ PCR assays for low-level, reliable mutation detection These kits are for Research Use Only (RUO) Not for use in diagnostic purposes FORT COLLINS, Colo. -- GT Molecular, Inc., a company providing ultrasensitive PCR assays for cancer research, pathogen detection, and wastewater-based epidemiology testing is entering the cancer molecular assay [...]
June 1, 2023
Shimadzu Corporation released the Peakintelligence for GCMS Ver. 2 software for triple quadrupole gas chromatograph mass spectrometers (GC-MS/MS) on June 1. This software makes it possible for anyone to easily analyze data acquired from a GC-MS/MS using Shimadzu’s proprietary artificial intelligence (AI) algorithms. In addition to the Smart Metabolites Database *1, which was introduced in Ver.1 *2 released [...]
May 31, 2023
RNA fusions can be used as biomarkers to identify cancer sub-types and monitor for residual disease SOUTH SAN FRANCISCO, Calif. -- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and CeGaT GmbH, a global provider of sequencing services for research, clinical studies, and [...]
Innovative, fully defined hydrogel sets new benchmark in 3D Cell Culture.
May 31, 2023
AMSBIO announce MatriMix – a groundbreaking 3D culture substrate. This pioneering hydrogel sets a new benchmark in the field, containing fully defined components, including medical grade collagens, laminin-511 E8 fragments, and hyaluronic acid. The high lot-to-lot consistency of MatriMix enables researchers to obtain highly reproducible results. MatriMix overcomes the limitations of current 3D substrates, enabling cutting-edge applications such as [...]
DNAnexus Platform Streamlines Access and Analysis for Large-Scale Proteomics Data
May 31, 2023
Company to host webinar featuring tips for managing large-scale proteomics data on UK Biobank Research Analysis Platform MOUNTAIN VIEW, Calif. — DNAnexus Inc., the leading provider of cloud-based genomic and biomedical data access and companion analysis software, today announced its core platform and Cohort Browser are now optimized for accessing and analyzing large-scale proteomics [...]
Vazyme Signs Global Strategic Cooperation Agreement with Azenta
May 31, 2023
NANJING, China -- Vazyme (688105.SH), China's leading biotechnology company, has officially signed a global strategic cooperation agreement with Azenta Life Sciences ("Azenta", Nasdaq: AZTA), which will promote to establish "one-stop" service process for both companies in the fields of next-generation sequencing, automated library preparation, raw material supply, experimental consumables, sample storage and more. Dr. Nie Junwei, General Manager of [...]
May 31, 2023
New Tapestri® v3 brings a higher number of cells captured and greater standardization and robustness to single-cell DNA and multi-omics workflows to empower customer success SOUTH SAN FRANCISCO, CA – Mission Bio, Inc. the pioneer in high-throughput single-cell DNA and multi-omics analysis, today announced breakthrough improvements to the Tapestri® Platform and its core chemistry that enable highly [...]
May 31, 2023
RNA fusions can be used as biomarkers to identify cancer sub-types and monitor for residual disease SOUTH SAN FRANCISCO, Calif. -- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and CeGaT GmbH, a global provider of sequencing services for research, clinical studies, and [...]
Almaden Genomics Names Board of Advisors
May 31, 2023
DALLAS, TEXAS – Almaden Genomics has announced its Board of Advisors, a highly regarded group of healthcare leaders from both the public and private sectors with experience in cancer research, presicion medicine, biotechnology, clinical trials, bioinformatics, data visualization, computational analysis, pharmacology, and AI. The Board – which includes Adrian Lee, Ph.D., Samir Courdy; Rayna Herman; Graham [...]

